News & Updates

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

30 Sep 2023 by

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in significant weight loss in patients with obesity or overweight without diabetes, a study has shown. In addition, the best GLP-1RA agent appears to be semaglutide, showing superior efficacy and low-to-moderate risk of side effects.

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

30 Sep 2023

Use of 5αRI does not increase cardiovascular risk in men with BPH

30 Sep 2023

Treatment with five-alpha reductase inhibitors (5αRIs) does not appear to elevate the risk of hospitalization for heart failure (HF), myocardial infarction (MI), stroke, or cardiovascular death among men with benign prostatic hyperplasia (BPH), a study has shown.

Use of 5αRI does not increase cardiovascular risk in men with BPH

30 Sep 2023

Anabolic steroid use may lead to persistent sperm damage

30 Sep 2023

Most men with a history of anabolic steroid use have severe oligospermia, with only a few of them achieving normal semen parameters after 6 months of treatment, according to a study.

Anabolic steroid use may lead to persistent sperm damage

30 Sep 2023

Postop opioids up risks of persistent opioid use, emergency visits, readmission and all-cause mortality

30 Sep 2023 by

A large retrospective cohort study by the University of Hong Kong (HKU) finds that postoperative prescription of opioids is associated with increased risks of new persistent opioid use, 30-day emergency department visits, 30-day readmission, and 30-day all-cause mortality.

Postop opioids up risks of persistent opioid use, emergency visits, readmission and all-cause mortality

30 Sep 2023

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

29 Sep 2023

Treatment with the oral form of nalbuphine, PHN131, appears to effectively control moderate-to-severe pain in patients who have undergone hemorrhoidectomy, according to a study.

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

29 Sep 2023

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

29 Sep 2023 by

Aldosterone synthase inhibition with lorundrostat confers substantial blood pressure (BP)-lowering benefit in people with uncontrolled hypertension, while having a favourable safety profile, according to data from the phase II Target-HTN trial.

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

29 Sep 2023

Clashes between young and old predict negative age stereotyping

29 Sep 2023 by

Using content on older adults mined from TikTok, one of the fastest growing social media platforms today, researchers from the National University of Singapore (NUS) found that negative encounters with older adults significantly predicted negative age stereotyping.

Clashes between young and old predict negative age stereotyping

29 Sep 2023

Pretreatment serum CEA level predicts survival in NSCLC

29 Sep 2023

Pretreatment level of serum carcinoembryonic antigen (CEA) is independently associated with overall and disease-free survival among patients with nonsmall cell lung cancer (NSCLC), reports a study. The same marker is also used for the prognosis of patients with the same pathologic stages.

Pretreatment serum CEA level predicts survival in NSCLC

29 Sep 2023

Noninvasive inverted urothelial papillary tumour tied to low recurrence, better outcomes

29 Sep 2023

Noninvasive urothelial papillary lesions of the bladder with an inverted growth pattern appear to have a low chance of recurrence and are associated with better outcomes, suggests a study.

Noninvasive inverted urothelial papillary tumour tied to low recurrence, better outcomes

29 Sep 2023

Selenium, zinc help prevent CKD development

29 Sep 2023 by

Higher blood concentrations of heavy metals appear to contribute to chronic kidney disease (CKD), while elevated levels of plasma selenium and serum zinc reduce CKD risk, according to a Singapore study.

Selenium, zinc help prevent CKD development

29 Sep 2023

News & Updates

Filter by Specialty:

Specialty:

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

GLP-1RAs reduce weight in overweight/obese individuals without diabetes

Use of 5αRI does not increase cardiovascular risk in men with BPH

Use of 5αRI does not increase cardiovascular risk in men with BPH

Anabolic steroid use may lead to persistent sperm damage

Anabolic steroid use may lead to persistent sperm damage

Postop opioids up risks of persistent opioid use, emergency visits, readmission and all-cause mortality

Postop opioids up risks of persistent opioid use, emergency visits, readmission and all-cause mortality

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

Clashes between young and old predict negative age stereotyping

Clashes between young and old predict negative age stereotyping

Pretreatment serum CEA level predicts survival in NSCLC

Pretreatment serum CEA level predicts survival in NSCLC

Noninvasive inverted urothelial papillary tumour tied to low recurrence, better outcomes

Noninvasive inverted urothelial papillary tumour tied to low recurrence, better outcomes

Selenium, zinc help prevent CKD development

Selenium, zinc help prevent CKD development